Halozyme Therapeutics Inc (NASDAQ:HALO)

18.60
Delayed Data
As of May 18
 +0.31 / +1.69%
Today’s Change
11.41
Today|||52-Week Range
21.48
-8.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.9B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders41.64%
Other institutional32.87%
Individual stakeholders19.53%

Top Executives

There are no executives to display.